AMRI, a global CRO, has added Saravanakumar Dhakshinamoorthy, Ph.D., to the ranks of its management team in Singapore, serving as director of in vitro biology.
Dhakshinamoorthy and his team will be working closely with on-site colleagues supporting customer projects, as well as in collaboration with AMRI's U.S.-based biology and DMPK teams. Dhakshinamoorthy comes to AMRI after seven years with Aurigene, a discovery services company in Bangalore, India. He previously worked in Singapore with the Institute of Molecular and Cell Biology. He brings more than 20 years of postgraduate experience in academic and industrial settings to AMRI.
"In this newly created role, Dr. Dhakshinamoorthy brings senior-level in vitro biology expertise, a strong track record of industry experience and additional drug discovery project management experience to the Singapore site," said Dr. Yura.